Health Care

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Stock Traded Above Its 50 Day Average

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Stock Traded Above Its 50 Day Average”

Therefore 71% are positive.

Agios Pharmaceuticals has with a one year low of $39.24 and a one year high of $67.74 and has a market capitalization of $0.

The closing price represents the final price that a stock is traded for on a trading day. Finally, BidaskClub upgraded Agios Pharmaceuticals from a hold rating to a buy rating in a report on Thursday, July 13th. On Wednesday, March 30 the stock rating was initiated by SunTrust with "Buy". Suntrust Robinson has "Buy" rating and $65 target. The rating was initiated by Northland Capital with "Outperform" on Thursday, July 23. They issued an "outperform" rating and a $78.00 target price for the company. SunTrust Banks, Inc. reiterated a buy rating and issued a $80.00 target price (up previously from $68.00) on shares of Agios Pharmaceuticals in a report on Tuesday, August 8th. BTIG Research initiated the stock with "Neutral" rating in Friday, August 19 report. The Firm operates through two divisions: Risk Assessment and Decision Analytics. It has a 20.16 P/E ratio.

Agios Pharmaceuticals, Inc., launched on August 7, 2007, is a clinical-stage biopharmaceutical company. The stock's market cap is $3.21 billion. The Company is engaged in the discovery and development of orally available small molecule medicines for the treatment of cancer and rare genetic disorders (RGDs), which are a subset of orphan genetic metabolic diseases. It now has negative earnings. Its cancer product candidates are AG-221 and AG-120, which targets mutated isocitrate dehydrogenase 2 and 1, or IDH2 and IDH1, respectively, and AG-881, which targets both mutated IDH1 and mutated IDH2.

Agios Pharmaceuticals (NASDAQ:AGIO) last released its earnings results on Thursday, February 16th. The biopharmaceutical company reported ($1.78) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.57) by ($0.21). After $-1.78 actual EPS reported by Agios Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts -2.25% EPS growth.

Since March 20, 2017, it had 0 insider purchases, and 8 insider sales for $1.26 million activity. Biller Scott also sold $124,532 worth of Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares. $150,180 worth of Agios Pharmaceuticals Inc (NASDAQ:AGIO) was sold by Schenkein David P. Agios Pharmaceuticals's revenue for the quarter was up 62.1% compared to the same quarter a year ago.

Traders are a little more bullish on Agios Pharmaceuticals, Inc. of late if you take a look at the change in short interest. It has underperformed by 8.18% the S&P500.

Investors sentiment decreased to 0.57 in Q4 2016. Its up 0.71, from 1.33 in 2016Q3. The total value of its holdings increased 186.1%. 19 funds opened positions while 56 raised stakes. Finally, Vanguard Group Inc. increased its position in shares of Agios Pharmaceuticals by 10.1% in the second quarter. Vanguard Group Inc. raised its position in Agios Pharmaceuticals by 23.8% during the 2nd quarter. Credit Suisse Ag invested in 0.01% or 128,133 shares. Lafayette Investments holds 96,054 shares or 0.1% of its portfolio. Ameriprise reported 0% stake. It worsened, as 2 investors sold Dover Motorsports, Inc. shares while 7 reduced holdings. Principal Fincl Gp Inc has 0% invested in Agios Pharmaceuticals Inc (NASDAQ:AGIO). Timber Hill Lc invested 0% in Dover Motorsports, Inc. The short interest to Agios Pharmaceuticals Incorporated's float is 18.77%. Moreover, Oxford Asset Mngmt has 0.08% invested in Agios Pharmaceuticals Inc (NASDAQ:AGIO) for 40,276 shares. Teacher Retirement System of Texas now owns 3,921 shares of the biopharmaceutical company's stock worth $164,000 after buying an additional 1,136 shares during the last quarter. The stock decreased 4.55% or $0.1 during the last trading session, reaching $2.1. About shares traded. Verisk Analytics, Inc. Dover Motorsports, Inc. (NYSE:DVD) has declined 11.76% since September 15, 2016 and is downtrending. It has underperformed by 12.68% the S&P500. (NASDAQ:VRSK) to report earnings on November, 7. Next quarter's EPS is estimated at $-1.81 and the next full year EPS is anticipated to be $-7.48. On Monday, October 24 the stock rating was initiated by Needham with "Buy". The lowest target is $88.0 while the high is $88.0. The stock was sold at an average price of $55.00, for a total transaction of $118,030.00.



Like this

Latest


16 September 2017
Market Monitor: SuperTrend Line Below Share Price: Vanguard Ftse Europe Shares Etf
The latest reading places the stock above the Ichimoku cloud which indicates positive momentum and a potential buy signal. Used as a coincident indicator, the CCI reading above +100 would reflect strong price action which may signal an uptrend.

16 September 2017
Altria Group (NYSE:MO) Shares Bought by CIBC World Markets Inc
More interesting news about Altria Group Inc (NYSE:MO) were released by: Fool.com and their article: "2 Reasons Altria Group Inc". Other institutional investors and hedge funds have also recently made changes to their positions in the company.

16 September 2017
Major fire breaks out at the famous RK Studios
The first movie produced by the RK Studio was "Aag", which came in the same year of its establishment. The studio has iconic films like Awaara, Boot Polish, Shri 420 and Jaagte Raho to its credit.

16 September 2017
Gov. Justice pushes for road bond approval
However, the "lion's share" of the jobs would be expected to be awarded in the spring, if the referendum passes, Justice said. Residents who intend to vote in the October 7 bond referendum but are not registered have until September 18 to register.

16 September 2017
What Are Analysts Suggestions On Costco Wholesale Corporation (COST)
Also, it has an estimated price-earnings (P/E) multiple of 25.27 and a trailing 12-month price-earnings (P/E) multiple of 28.16. The retailer reported $1.24 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.19 by $0.05.

16 September 2017
ACB raids Goa opposition leader's residence
It has also said that the government should consider referring the matter to the Central Bureau of Investigation (CBI). The state government was trying its best to demoralise the opposition through such tactics, he alleged.

16 September 2017
Ruthless All Blacks thrash South Africa in Rugby Championship
After racing away on the left he found Coles in support and the hooker offloaded to Retallick for the finishing touch. Milner-Skudder went on to score a double, as the All Blacks crushed South Africa 57-0.

16 September 2017
Stormzy set to join 'The X Factor'
She added: "It's interesting because I have a feeling about somebody who is going to win - but they're not in my category". The post comes amid rumours that Cheryl, 34, could be returning to The X Factor to join Simon at his Judges' Houses.

16 September 2017
Provide relief in cases of unnatural jail death, says SC
Amicus Curiae advocate Gaurav Agarwal had suggested that states must be encouraged to establish open jails. It asked the states to conduct a study on overall conditions in jails and the facilities available.

16 September 2017
Terrorists Killed In Jammu And Kashmir's Machil Sector, Infiltration Bid Foiled
The infiltration bid comes in the midst of a series of ceasefire violation cases by Pakistan Army. The identities and affiliation of the suspected militants is not known yet, Kalia added.